medigraphic.com
Colegio de Medicina Interna de México.

2015, Number 1

<< Back Next >>

Med Int Mex 2015; 31 (1)

Ferritin: A risk factor in ischemic heart disease?

Flores-López EN, Aguilar-de la Torre DL, García-Padilla E, Silva-Nolasco R

Language: Spanish
References: 78
Page: 57-63
PDF size: 465.70 Kb.


ABSTRACT

The relationship between ferritin and cardiovascular risk has been studied largely without accurate conclusions so far. Since ferritin has potential antioxidant serum properties, as a source of endogenous production of them, may host cell anti-ischemic characteristics that can potentially confer important clinical implications in ischemic heart disease; numerous articles have attempted to find an association between these characteristics, but in Latin America there are still no studies that define the characteristics of ferritin in patients with ischemic heart disease.


REFERENCES

  1. Pantopoulos K, Porwal SK, Tartakoff A, Devireddy L. Mechanisms of mammalian iron homeostasis. Biochemistry 2012;51:5705-5724.

  2. Paredes-Aguilera R. Metabolismo del hierro. Rev Mex Med Tran 2009;2:87-89.

  3. De Silva N, Davis B. Iron, B12 and folate. Medicine 2012;41:204-207.

  4. Del Castillo-Rueda A. Protocolo diagnóstico de las ferritinemias elevadas 2008;10:1299-1301.

  5. Muñoz M, Villar I, García-Erce JA. An update on iron physiology. World J Gastroenterol 2009;15:4617-4626.

  6. Holay MP, Choudhary AA, Suryawanshi SD. Serum ferritin-a novel risk factor in acute myocardial infarction. Indian Heart J 2012:173-177.

  7. Recalcati S, Invernizzi P, Arosio P, Cairo G. New functions for an iron storage protein: The role of ferritin in immunity and autoimmunity. J Autoimmun 2008;30:84-89.

  8. Sempos CT, Looker AC, Gillum RE, McGee DL, et al. Serum ferritin and death from all causes and cardiovascular disease: the NHANES II Mortality Study. National Health and Nutrition Examination Study. Ann Epidemiol 2000;10:441- 448.

  9. Salonen JT, Nyyssönen K, Korpela H, Tuomilehto J, et al. High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men. Circulation 1992;86:803-811.

  10. Magnusson MK, Sigfusson N, Sigvaldason H, Johannesson GM, et al. Low iron-binding capacity as a risk factor for myocardial infarction. Circulation 1994;89:102-108.

  11. Stampfer MJ, Grodstein F, Rosenberg I, Willett W, Hennekens C. A prospective study of plasma ferritin and risk of myocardial infarction in US physicians. Circulation 1993;87:688.

  12. Mänttäri M, Manninen V, Huttunen JK, Palosuo T, et al. Serum ferritin and ceruloplasmin as coronary risk factors. Eur Heart J 1994;15:1599-1603.

  13. Frey GH, Krider DW. Serum ferritin and myocardial infarct. West Virginia Medical J 1994;90:13-15.

  14. Kiechl S, Willeit J, Egger G, Poewe W, Oberholenzer F. Body iron stores and the risk of carotid atherosclerosis. Circulation 1997;96:3300-3307.

  15. Aronow WS, Ahn C. Three-year follow-up shows no association of serum ferritin levels with incidence of new coronary events in 577 persons aged >62 years. Am J Cardiol 1996;78:678-679.

  16. Salonen JT, Nyyssonen K, Salonen R. Body iron stores and the risk of coronary heart disease. N Engl J Med 1994;331:1159.

  17. Toumainen TP, Punnonen K, Nyyssonen K, Salonen JT. Association between body iron stores and the risk of acute myocardial infarction. Circulation 1998;1461-1466.

  18. Aronow WS. Serum ferritin is not a risk factor for coronary artery disease in men and women aged >62 years. Am J Cardiol 1993;72:347-348.

  19. Solymoss BC, Marcil M, Gilfix BM, Gelinas F, et al. The place of ferritin among risk factors associated with coronary artery disease. Coron Artery Dis 1994;5:231-235.

  20. Rauramaa R, Vaisanen S, Mercuri M, Rankinen T, et al. Association of risk factors and body iron status to carotid atherosclerosis in middle-aged Eastern Finnish men. Eur Heart J 1994;15:1020-1027.

  21. Kiechl S, Aichner F, Gerstenbrand F, Egger G, et al. Body iron stores and presence of carotid atherosclerosis. Results from the Bruneck Study. Arterioscler Thromb 1994;14:1625-1630.

  22. Duthie GG, Beattie JAG, Arthur JR, Franklin M, et al. Blood antioxidants and indices of lipid peroixidation in subjects with stable angina. Nutrition 1994;10:313-316.

  23. Rengstrom J, Tonrvall P, Kallner A, Nilsson J, Hamsten A. Stored iron levels and myocardial infarction at a young age. Atherosclerosis 1994;106:123-125.

  24. Moore M, Folsom AR, Barnes RW, Eckfeldt JH. No association between serum ferritin and asymptomatic carotid atherosclerosis.The Atherosclerosis Risk in Communities (ARIC) Study. Am J Epidemiol 1995;141:719-723.

  25. van der Schouw YT, Verbeek A, Ruijs J. ROC curves for the initial assessment of new diagnostic tests. Family Practice 1992;9:506-511.

  26. Eichner JE, Qi H, Moorre WE, Schechter E. Iron measures in coronary angiography patients. Atherosclerosis 1998;136:241-245.

  27. Sempos CT, Looker AC, Gillum RF, Makuc DM. Body iron stores and the risk of coronary heart disease. N Engl J Med 1994;330:1119-1124.

  28. Liao Y, Cooper RS, McGee DL. Iron status and coronary heart disease: Negative findings from the NHANES I Epidemiologic Follow-up Study. Am J Epidemiol 1994;139:704-712.

  29. Baer DM, Tekawa IS, Hurley LB. Iron stores are not associated with acute myocardial infarction. Circulation 1994;89:2915-2918.

  30. Reunanen A, Takkunen H, Knekt P, Sappanen R, Aromaa A. Body iron stores, dietary iron intake and coronary heart disease mortality. J Intern Med 1995;238:223-230.

  31. van Asperen IA, Feskens EJ, Bowels CH, Kromhout D. Body iron stores and mortality due to cancer and ischemic heart disease: A 17- year follow-up study of elderly men and women. Int J Epidemiol 1995 24:665-670.

  32. Morrison HI, Semenciw RM, Mao Y, Wigle DT. Serum iron and fatal acute myocardial infarction. Epidemiology 1994;5:243-246.

  33. Corti MC, Guralnik JM, Salvie ME, Ferrucci L, et al. Serum iron level, coronary artery disease, and all cause mortality in older men and women. Am J Cardiol 1997;79:120-127.

  34. Reaven PD, Witztum JL. Oxidized low density lipoproteins in atherogenesis: role of dietary modification. Annu Rev Nutr 1996;16:51-71.

  35. Heinecke JW. Oxidants and antioxidants in the pathogenesis of atherosclerosis: Implications for the oxidized low density protein hypothesis. Atherosclerosis 1998;141:1-15.

  36. Yuan XM, Brunk UT. Iron and LDL-oxidation in atherogenesis. APMIS 1998;106:825-842.

  37. Endbergs A, Dorzewski A, Luft M, Monnig G, et al. Failure to confirm ferritin and caeruloplasmin as risk factors for the angiographic extent of coronary atherosclerosis. Coronary Art Dis 1998;9:119-124.

  38. Salonen JT, Korpela H, Nyyssonen K, Porkkala E, et al. Lowering of body iron stores by blood letting and oxidation resistence of serum lipoproteins: A randomized crossover trial in male smokers. J Intern Med 1995;237:161- 168.

  39. Weintraub WS, Wenger NK, Parthasaranthy S, Brown WV. Hyperlipidemia versus iron overload and coronary heart disease: Yet more arguments on the cholesterol debate. J Clin Epidemiol 1996;49:1353-1358.

  40. Halevy D, Thiery J, Nagel D, Arnold S, et al. Increased oxidation of LDL in patients with coronary artery disease is independent from dietary vitamins E and C. Arterioscler Thromb Vasc Biol 1997;17:1432-1437.

  41. Iribarren C, Sempos CT, Eckfeldt JH, Folsom A. Lack of association between ferritin level and measures of LDL oxidation. The ARIC Study. Atherosclerosis 1998;139:189- 195.

  42. Craig WY, Poulin SE, Palomaki GE, Neveux LM, et al. Oxidation-related analytes and lipid and lipoprotein concentrations in adults. Arterioscler Thromb Vasc Biol 1995;15:733-739.

  43. Zock PL, Katan MB. Diet, LDL oxidation, and coronary artery disease. Am J Clin Nutr 1998;68:759-760.

  44. Maggi E, Chiesa R, Melissano G, Castellano R, et al. LDL oxidation in patients with severe carotid atherosclerosis. A study of in vitro and in vivo oxidation markers. Arterioscler Thromb 1994;14:1892-1899.

  45. Iribarren C, Folsom AR, Jacobs DR, Gross MD, et al. Association of serum vitamin levels, LDL susceptibility to oxidation, and autoantibodies against MDA-LDL with carotid atherosclerosis. Arterioscler Thromb Vasc Biol 1997;17:1171-1177.

  46. Custer EM, Finch CA, Sobel RE, Zettner A. Populations norms for serum ferritin. J Lab Clin Med 1995;126:88-94.

  47. Gabay C, Kushner I. Acute-phase proteins and other systematic responses to inflammation. N Engl J Med 1999;340:448-454.

  48. Danesh J, Collins R, Appleby P, Peto R. Fibrinogen, C-reactive protein, albumin or white cell count: Meta-analysis of prospective studies of coronary heart disease. JAMA 1998;279:1477-1482.

  49. Gillum RF, Mussolino ME, Makuc DM. Erythrocyte sedimentation rate and coronary heart disease: The NHANES I Epidemiologic Follow-up Study. J Clin Epidemiol 1995;48:353-361.

  50. Salonen JT, Nyyssonen K, Korpela H, et al. High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men. Circulation 1992;86:803-811.

  51. Knuiman MW, Divitini ML, Olynyk JK, Cullen DJ, Bartholomew HC. Serum ferritin and cardiovascular disease: a 17-year follow-up study in Busselton, Western Australia. Am J Epidemiol 2003;158:144-149.

  52. Danesh J, Appleby P. Coronary heart disease and iron status: meta-analyses of prospective studies. Circulation 1999;99:852-854.

  53. Friedrich N, Milman N, Volzke H, Linneberg A, Jorgensen T. Is serum ferritin within the reference range a risk predictor of cardiovascular disease? A population-based, long-term study comprising 2874 subjects. Br J Nutr 2009;102:594-600.

  54. Wolff B, Volzke H, Ludemann J, et al. Association between high serum ferritin levels and carotid atherosclerosis in the study of health in Pomerania (SHIP). Stroke 2004;35:453- 457.

  55. Kiechl S, Willeit J, Egger G, Poewe W, Oberhollenzer F. Body iron stores and the risk of carotid atherosclerosis: prospective results from the Bruneck study. Circulation 1997;96:3300-3307.

  56. Menke A, Fernandez-Real JM, Muntner P, Guallar E. The association of biomarkers of iron status with peripheral arterial disease in US adults. BMC Cardiovasc Disord 2009;9:34.

  57. Haidari M, Javadi E, Sanati A, Hajilooi M, Ghanbili J. Association of increased ferritin with premature coronary stenosis in men. Clin Chem 2001;47:1666-1672.

  58. Ikeda Y, Suehiro T, Yamanaka S, et al. Association between serum ferritin and circulating oxidized low-density lipoprotein levels in patients with type 2 diabetes. Endocr J 2006;53:665-670.

  59. Depalma RG, Hayes VW, Chow BK, et al. Ferritin levels, inflammatory biomarkers, and mortality in peripheral arterial disease: a substudy of the Iron (Fe) and Atherosclerosis Study (FeAST) Trial. J Vasc Surg 2010;51:1498-1503.

  60. van Tits LJ, Jacobs EM, Swinkels DW, et al. Non-transferrin- bound iron is associated with plasma level of soluble intercellular adhesion molecule-1 but not with in vivo low-density lipoprotein oxidation. Atherosclerosis 2007;194:272-278.

  61. Tuomainen TP, Diczfalusy U, Kaikkonen J, Nyyssonen K, Salonen JT. Serum ferritin concentration is associated with plasma levels of cholesterol oxidation products in man. Free Radic Biol Med 2003;35:922-928.

  62. Brouwers A, Langlois M, Delanghe J, et al. Oxidized lowdensity lipoprotein, iron stores, and haptoglobin polymorphism. Atherosclerosis 2004;176:189-195.

  63. Brudevold R, Hole T, Hammerstrom J. Hyperferritinemia is associated with insulin resistance and fatty liver in patients without iron overload. PLoS One 2008;3:3547.

  64. Gillum RF. Association of serum ferritin and indices of body fat distribution and obesity in Mexican American men—the Third National Health and Nutrition Examination Survey. Int J Obes Relat Metab Disord 2001;25:639-645.

  65. Fernandez-Real JM, Ricart-Engel W, Arroyo E, et al. Serum ferritin as a component of the insulin resistance syndrome. Diabetes Care 1998;21:62-68.

  66. Tuomainen TP, Nyyssonen K, Salonen R, et al. Body iron stores are associated with serum insulin and blood glucose concentrations. Population study in 1,013 eastern Finnish men. Diabetes Care 1997;20:426-428.

  67. Stadler N, Lindner RA, Davies MJ. Direct detection and quantification of transition metal ions in human atherosclerotic plaques: evidence for the presence of elevated levels of iron and copper. Arterioscler Thromb Vasc Biol 2004;24:949-954.

  68. Lapenna D, Pierdomenico SD, Ciofani G, et al. Association of body iron stores with low molecular weight iron and oxidant damage of human atherosclerotic plaques. Free Radic Biol Med 2007;42:492-498.

  69. Stanley N, Stadler N, Woods AA, Bannon PG, Davies MJ. Concentrations of iron correlate with the extent of protein, but not lipid, oxidation in advanced human atherosclerotic lesions. Free Radic Biol Med 2006;40:1636-1643.

  70. Stocker R, Keaney JF Jr. Role of oxidative modifications in atherosclerosis. Physiol Rev 2004;84:1381-1478.

  71. Kraml PJ, Klein RL, Huang Y, Nareika A, Lopes-Virella MF. Iron loading increases cholesterol accumulation and macrophage scavenger receptor I expression in THP-1 mononuclear phagocytes. Metabolism 2005;54:453-459.

  72. Yuan XM, Li W, Baird SK, Carlsson M, Melefors O. Secretion of ferritin by iron-laden macrophages and influence of lipoproteins. Free Radic Res 2004;38:1133-1142.

  73. Li W, Ostblom M, Xu LH, et al. Cytocidal effects of atheromatous plaque components: the death zone revisited. Faseb J 2006;20:2281-2290.

  74. Holay MP, Choudhary AA, Suryawanshi SD. Serum ferritin-a novel risk factor in acute myocardial infarction. Indian Heart J 2012;64:173-177.

  75. Dominguez-Rodriguez A, Carrillo-Perez Tome M, Hernandez- Garcia C, Arroyo-Ucar E, et al. Serum ferritin and acute coronary syndrome: a strong prognostic factor? Int J Cardiol 2011;152:129-130.

  76. Yalta K, Sivri N, Yalta T, Yetkin E. Serum ferritin: a potential determinant of myocardial ischemic burden in the setting of ischemic conditions? Int J Cardiol 2011;153:225-226.

  77. Loncar R, Flesche CW, Deussen A. Myocardial ferritin content is closely related to the degree of ischaemia. Acta Physiol Scand 2004;180:21-28.

  78. Okonko DO, Grzeslo A, Witkowski T, Mandal AK, et al. Effect of intravenous iron sucrose on exercise tolerance in anemic and nonanemic patients with symptomatic chronic heart failure and iron deficiency FERRIC-HF: a randomized, controlled, observer-blinded trial. J Am Coll Cardiol 2008;51:103-112.




2020     |     www.medigraphic.com